NCT05926232|Unknown
Expanded Access for Repotrectinib
1 other identifier
CA127-1057
Study Type
expanded_access
Target
N/A
Locations
0 countries
Sites
N/A
Timeline
RegisteredJul 2023
Brief Summary
This is an expanded access designed to provide access to Repotrectinib for eligible participants.
Trial Health
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 21, 2023
Completed12 days until next milestone
First Posted
Study publicly available on registry
July 3, 2023
CompletedLast Updated
July 3, 2023
Status Verified
June 1, 2023
First QC Date
June 21, 2023
Last Update Submit
June 30, 2023
Interventions
Eligibility Criteria
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
MeSH Terms
Interventions
repotrectinib
Study Officials
- STUDY DIRECTOR
Bristol-Myers Squibb
Bristol-Myers Squibb
Central Study Contacts
BMS Study Connect Contact Center http://www.bmsstudyconnect.com
CONTACT
First line of the email MUST contain NCT # and Site #.
CONTACT
Study Design
- Study Type
- expanded access
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 21, 2023
First Posted
July 3, 2023
Last Updated
July 3, 2023
Record last verified: 2023-06